$2.51T
Total marketcap
$67.94B
Total volume
BTC 50.12%     ETH 16.14%
Dominance

PURE Bioscience PURE Stock

0.08 USD {{ price }} 5.263159% {{change_pct}}%
Exchange
Other OTC
Market Cap
8.95M USD
LOW - HIGH [24H]
0.08 - 0.08 USD
VOLUME [24H]
14.12K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.04 USD

PURE Bioscience Price Chart

PURE Bioscience PURE Financial and Trading Overview

PURE Bioscience stock price 0.08 USD
Previous Close 0.13 USD
Open 0.12 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.08 - 0.12 USD
52 Week Range 0.07 - 0.24 USD
Volume 397.9K USD
Avg. Volume 47.9K USD
Market Cap 9.98M USD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -0.04 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

PURE Valuation Measures

Enterprise Value 13.36M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 5.915994
Price/Book (mrq) 8.147727
Enterprise Value/Revenue 7.92
Enterprise Value/EBITDA -3.614

Trading Information

PURE Bioscience Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -55.0000000000000071%
S&P500 52-Week Change 20.43%
52 Week High 0.24 USD
52 Week Low 0.07 USD
50-Day Moving Average 0.12 USD
200-Day Moving Average 0.14 USD

PURE Share Statistics

Avg. Volume (3 month) 47.9K USD
Avg. Daily Volume (10-Days) 89.73K USD
Shares Outstanding 111.36M
Float 65.43M
Short Ratio 2.56
% Held by Insiders 41.23%
% Held by Institutions 0%
Shares Short 222.97K
Short % of Float 1.85%
Short % of Shares Outstanding 1.82%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:8

Financial Highlights

Fiscal Year

Fiscal Year Ends July 31, 2022
Most Recent Quarter (mrq) April 30, 2023
Next Fiscal Year End July 31, 2023

Profitability

Profit Margin -246.71%
Operating Margin (ttm) -228.21%
Gross Margin 45.16%
EBITDA Margin -219.14%

Management Effectiveness

Return on Assets (ttm) -122.083%
Return on Equity (ttm) -294.86%

Income Statement

Revenue (ttm) 1.69M USD
Revenue Per Share (ttm) 0.02 USD
Quarterly Revenue Growth (yoy) -22.30%
Gross Profit (ttm) 1M USD
EBITDA -3697000 USD
Net Income Avi to Common (ttm) -4162000 USD
Diluted EPS (ttm) -0.04
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 781K USD
Total Cash Per Share (mrq) 0.007 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 2.162
Book Value Per Share (mrq) 0.011

Cash Flow Statement

Operating Cash Flow (ttm) -3137000 USD
Levered Free Cash Flow (ttm) -1615875 USD

Profile of PURE Bioscience

Country United States
State CA
City Rancho Cucamonga
Address 9669 Hermosa Avenue
ZIP 91730
Phone 619 596 8600
Website https://www.purebio.com
Industry Household & Personal Products
Sector(s) Consumer Defensive
Full Time Employees 15

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.

Q&A For PURE Bioscience Stock

What is a current PURE stock price?

PURE Bioscience PURE stock price today per share is 0.08 USD.

How to purchase PURE Bioscience stock?

You can buy PURE shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for PURE Bioscience?

The stock symbol or ticker of PURE Bioscience is PURE.

Which industry does the PURE Bioscience company belong to?

The PURE Bioscience industry is Household & Personal Products.

How many shares does PURE Bioscience have in circulation?

The max supply of PURE Bioscience shares is 111.86M.

What is PURE Bioscience Price to Earnings Ratio (PE Ratio)?

PURE Bioscience PE Ratio is now.

What was PURE Bioscience earnings per share over the trailing 12 months (TTM)?

PURE Bioscience EPS is -0.04 USD over the trailing 12 months.

Which sector does the PURE Bioscience company belong to?

The PURE Bioscience sector is Consumer Defensive.